Sulfanegen

Sulfanegen

Sulfanegen is a drug that is used as an antidote for cyanide poisoning. It works by converting cyanide into thiocyanate, a less toxic compound that is excreted in urine. Sulfanegen is a prodrug of 3-mercaptopyruvate, which is the actual compound that detoxifies cyanide.

History

Sulfanegen was first synthesized in the early 21st century as part of a research program funded by the National Institutes of Health (NIH) to develop new antidotes for cyanide poisoning. The drug was developed by scientists at the University of Minnesota and the University of California, San Francisco.

Mechanism of action

Sulfanegen is a prodrug of 3-mercaptopyruvate. After administration, it is converted into 3-mercaptopyruvate by the enzyme 3-mercaptopyruvate sulfurtransferase. 3-Mercaptopyruvate then reacts with cyanide to form thiocyanate, which is less toxic and can be excreted in the urine.

Clinical use

Sulfanegen is used as an antidote for cyanide poisoning. It can be administered intravenously or orally. The drug is particularly useful in situations where cyanide exposure is chronic or where the source of exposure cannot be immediately removed.

Side effects

Like all drugs, sulfanegen can cause side effects. The most common side effects are nausea and vomiting. In rare cases, sulfanegen can cause allergic reactions.

Research

Research on sulfanegen is ongoing. Current research focuses on improving the drug's formulation and delivery, as well as exploring its potential use in treating other conditions, such as sepsis and mitochondrial diseases.

See also

• Cyanide poisoning
• Antidote
• Prodrug
• 3-Mercaptopyruvate sulfurtransferase

Template:Chemical compounds Drug groups | Encyclopedia | Dictionary | Cancer drugs | OTC | Alternative meds | Drugs | Medications A-Z | FDA approved products | Portal:Pharmacology

‎